Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
Terminated
Guerbet
Phase 4
2009-01-01
The purpose of this study is to evaluate the contrast-induced nephropathy (CIN) rate in
subjects randomized to receive either Ioversol or Iodixanol for contrast-enhanced computed
tomography.
Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
Terminated
Mallinckrodt
Phase 4
2009-01-01
The purpose of this study is to evaluate the contrast-induced nephropathy (CIN) rate in
subjects randomized to receive either Ioversol or Iodixanol for contrast-enhanced computed
tomography.
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
Not yet recruiting
Bayer
Phase 4
2022-03-01
This is a Phase 4 multicenter prospective study to estimate the proportion of patients aged
birth to 3 years who develop hypothyroidism within 6 months after receiving intravascular
iohexol (Omnipaque™), iodixanol (Visipaque™), iopromide (Ultravist®), or ioversol (Optiray®)
as the iodinated contrast medium (ICM) for clinical evaluation during an ICM-enhanced
diagnostic imaging procedure.
Pediatric Risk of Hypothyroidism With Iodinated Contrast Media
Not yet recruiting
Duke Clinical Research Institute
Phase 4
2022-03-01
This is a Phase 4 multicenter prospective study to estimate the proportion of patients aged
birth to 3 years who develop hypothyroidism within 6 months after receiving intravascular
iohexol (Omnipaque™), iodixanol (Visipaque™), iopromide (Ultravist®), or ioversol (Optiray®)
as the iodinated contrast medium (ICM) for clinical evaluation during an ICM-enhanced
diagnostic imaging procedure.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
